ClinVar Genomic variation as it relates to human health
NM_000063.6(C2):c.954G>C (p.Glu318Asp)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000063.6(C2):c.954G>C (p.Glu318Asp)
Variation ID: 12130 Accession: VCV000012130.24
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 6p21.33 6: 31936027 (GRCh38) [ NCBI UCSC ] 6: 31903804 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 31, 2013 Sep 29, 2024 Jan 29, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000063.6:c.954G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000054.2:p.Glu318Asp missense NM_001145903.3:c.558G>C NP_001139375.1:p.Glu186Asp missense NM_001178063.3:c.347-1292G>C intron variant NM_001282457.2:c.216G>C NP_001269386.1:p.Glu72Asp missense NM_001282458.2:c.867G>C NP_001269387.1:p.Glu289Asp missense NC_000006.12:g.31936027G>C NC_000006.11:g.31903804G>C NG_011730.1:g.13539G>C LRG_26:g.13539G>C LRG_26t1:c.954G>C P06681:p.Glu318Asp - Protein change
- E318D, E72D, E186D, E289D
- Other names
-
C2, GLU318ASP
- Canonical SPDI
- NC_000006.12:31936026:G:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.02975 (C)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 30x 0.02904
1000 Genomes Project 0.02975
Trans-Omics for Precision Medicine (TOPMed) 0.03030
The Genome Aggregation Database (gnomAD) 0.03307
Exome Aggregation Consortium (ExAC) 0.03896
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
C2 | - | - |
GRCh38 GRCh38 GRCh38 GRCh38 GRCh38 GRCh38 GRCh38 GRCh37 |
281 | 390 | |
C2-AS1 | - | - | - |
GRCh38 GRCh38 GRCh38 GRCh38 GRCh38 GRCh38 GRCh38 |
- | 59 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely benign (2) |
criteria provided, single submitter
|
Apr 27, 2017 | RCV000012913.8 | |
Benign/Likely benign (2) |
criteria provided, multiple submitters, no conflicts
|
May 28, 2019 | RCV000304426.6 | |
Benign (4) |
criteria provided, single submitter
|
Mar 28, 2016 | RCV000454375.9 | |
Benign/Likely benign (3) |
criteria provided, multiple submitters, no conflicts
|
Jan 29, 2024 | RCV001516299.9 | |
Likely benign (1) |
criteria provided, single submitter
|
Apr 9, 2022 | RCV002496332.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Benign
(May 28, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Complement component 2 deficiency
Affected status: unknown
Allele origin:
unknown
|
Mendelics
Accession: SCV001137072.1
First in ClinVar: Jan 09, 2020 Last updated: Jan 09, 2020 |
|
|
Likely benign
(Apr 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Age related macular degeneration 14
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000461949.3
First in ClinVar: Dec 06, 2016 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. (less)
|
|
Likely benign
(Apr 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Complement component 2 deficiency
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000461950.3
First in ClinVar: Dec 06, 2016 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. (less)
|
|
Benign
(Jul 20, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001882547.1
First in ClinVar: Sep 19, 2021 Last updated: Sep 19, 2021 |
Comment:
This variant is associated with the following publications: (PMID: 9670930, 22610944, 25525159, 32113979, 16936732, 16518403)
|
|
Likely benign
(Apr 09, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Complement component 2 deficiency
Age related macular degeneration 14
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002806298.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Likely benign
(-)
|
criteria provided, single submitter
Method: not provided
|
not provided
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Breakthrough Genomics, Breakthrough Genomics
Accession: SCV005225529.1
First in ClinVar: Sep 29, 2024 Last updated: Sep 29, 2024 |
|
|
Benign
(Mar 28, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV000538519.1
First in ClinVar: Apr 09, 2017 Last updated: Apr 09, 2017 |
Comment:
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or … (more)
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF (less)
Method: Genome/Exome Filtration
|
|
Benign
(Jan 29, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001724564.4
First in ClinVar: Jun 15, 2021 Last updated: Feb 20, 2024 |
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not specified
Affected status: yes
Allele origin:
germline
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001957275.1 First in ClinVar: Oct 02, 2021 Last updated: Oct 02, 2021 |
|
|
Pathogenic
(Sep 01, 2006)
|
no assertion criteria provided
Method: literature only
|
MACULAR DEGENERATION, AGE-RELATED, 14, REDUCED RISK OF
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000033154.3
First in ClinVar: Apr 04, 2013 Last updated: Oct 31, 2013 |
Comment on evidence:
In approximately 900 individuals with ARMD (ARMD14; 615489) and approximately 400 controls, Gold et al. (2006) found a significant association between haplotype H10, consisting of … (more)
In approximately 900 individuals with ARMD (ARMD14; 615489) and approximately 400 controls, Gold et al. (2006) found a significant association between haplotype H10, consisting of the L9H variant (138470.0003) of the CFB gene and the glu318-to-asp (E318D; rs9332739) variant of the C2 gene, and a reduced risk of ARMD. Maller et al. (2006) replicated the association of the L9H variant of CFB and the E318D variant of C2 with risk of ARMD, noting that although this pair of SNPs has minor alleles that confer an equivalent protective effect, they found these effects to be independent and distinct. (less)
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not specified
Affected status: yes
Allele origin:
germline
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001739738.3 First in ClinVar: Jul 07, 2021 Last updated: Sep 08, 2021 |
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not specified
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001928698.1 First in ClinVar: Sep 24, 2021 Last updated: Sep 24, 2021 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. | Maller J | Nature genetics | 2006 | PMID: 16936732 |
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. | Gold B | Nature genetics | 2006 | PMID: 16518403 |
A novel type II complement C2 deficiency allele in an African-American family. | Zhu ZB | Journal of immunology (Baltimore, Md. : 1950) | 1998 | PMID: 9670930 |
Text-mined citations for rs9332739 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.